Heath-Chiozzi Margo's Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Dec 10, 2021
- Accession no.
- 0001179110-21-010818
- Filed
- Dec 10, 2021
- Trade date
- Dec 8, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $24.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Heath-Chiozzi MargoCIK 0001718112 | Officer (SVP of Regulatory Affairs) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2021 | Common Stock | MOption exerciseAcquired | +600 | $2.78 | +$1,668 | 11,847 | Direct | |
| Dec 8, 2021 | Common Stock | SSaleDisposed | −600 | $40.00 | −$24,000 | 11,247 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2021 | Common Stock | MOption exerciseDisposed | −600 | $0.00 | $0 | 41,800 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.